The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Drug Safety Update highlighting that healthcare professionals should be aware of alerts and letters issued about adrenaline auto-injectors in September and October 2019. 

Some of our content, including support alerts, is only available to RPS members. 

Log in

Find out more about membership of the Society